Matthew D. Seftel

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Lori Muffly, Marcelo C. Pasquini, Michael J. Martens et al. · Blood · 2017 · 296 citations · Full text

Medicine, Geriatric Medicine, Hematology +14

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos et al. · Blood · 2013 · 183 citations · Full text

Medicine, Oncology, Pharmacology +12

Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness

Matthew D. Seftel, Gershon H. Growe, Tanya Petraszko et al. · Blood · 2003 · 158 citations · Full text

Medicine, Hematology, Inflammation +11

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan et al. · Blood · 2012 · 134 citations · Full text

Medicine, Hematology, Toxicology +16

Eight Cycles of ABVD Versus Four Cycles of BEACOPP_escalatedPlus Four Cycles of BEACOPP_baselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Patrice Carde, Matthias Karrasch, Catherine Fortpied et al. · Journal of Clinical Oncology · 2016 · 121 citations

Medicine, Oncology, Pharmacology +15